Does the Intermittent Pringle Maneuver Affect the Recurrence Following Surgical Resection for Hepatocellular Carcinoma? A Systematic Review
Overview
Affiliations
Background And Aim: To evaluate the effect of intermittent pringle maneuver (IPM) on the long-term prognosis and recurrence of hepatocellular carcinoma (HCC).
Methods: Eligible studies were identified by PubMed and other databases from Jan 1st 1990 to Mar 31st 2019. Hazard ratios (HR) with 95% confidence interval (CI) were calculated to evaluate the effects of IPM on the long-term prognosis and recurrence of patients with HCC.
Results: Six studies were enrolled in this meta-analysis. Results showed that there were no differences between IPM group and non-IPM group in the pooled HRs for the overall survival (OS) and disease-free survival (DFS) (HR 1.04, 95%CI 0.84~1.28, P = 0.74; HR 0.93, 95%CI 0.81~1.07, P = 0.29; respectively). However, subgroup analysis showed that the pooled Odd ratios (OR) for the 1-year OS and DFS rates of the IPM group when compared with the non-IPM group were 0.65 (95% CI 0.45~0.94, P = 0.02), 0.38 (95% CI 0.20~0.72, P = 0.003), respectively. In addition, there were no significant differences in the proportions of liver cirrhosis, HBsAg (+), Child-Pugh A class, multiple tumor, vascular invasion, and major hepatectomy between groups of IPM and non-IPM.
Conclusion: Since IPM would increase the risk of early-recurrence, it should be used cautiously in the procedure of hepatectomy for resectable HCC. However, the current conclusion needs further validation.
Trial Registry Number: CRD 42019124923.
Tang S, Xu J, Yang Y, Shi J, Lin K, Kong J Ann Surg Oncol. 2023; 31(3):1812-1822.
PMID: 38038790 DOI: 10.1245/s10434-023-14642-6.
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
J Liver Cancer. 2023; 23(1):1-120.
PMID: 37384024 PMC: 10202234. DOI: 10.17998/jlc.2022.11.07.
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
Korean J Radiol. 2022; 23(12):1126-1240.
PMID: 36447411 PMC: 9747269. DOI: 10.3348/kjr.2022.0822.
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
Clin Mol Hepatol. 2022; 28(4):583-705.
PMID: 36263666 PMC: 9597235. DOI: 10.3350/cmh.2022.0294.
Wassmer C, Moeckli B, Berney T, Toso C, Orci L Cancers (Basel). 2021; 13(4).
PMID: 33562666 PMC: 7916026. DOI: 10.3390/cancers13040637.